Compare ImmunityBio Inc. Common Stock (IBRX) vs Match Group Inc (MTCH) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
ImmunityBio Inc. Common Stock vs Match Group Inc — how do they compare? ImmunityBio Inc. Common Stock trades at $9.99 (market cap $10.51B), while Match Group Inc trades at $41.48 (market cap $9.53B). The key difference: ImmunityBio Inc. Common Stock and Match Group Inc are close in size by market cap, and Match Group Inc pays a 1.93% dividend while ImmunityBio Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold ImmunityBio Inc. Common Stock for 0 Days and Match Group Inc for 115 Days on average.
| IBRX | MTCH | |
|---|---|---|
Market Cap | $10.51B | $9.53B |
Volume | 10,445,785 | 3,228,794 |
Sector | Health | Media |
52-Week High | $11.55 | $44.40 |
52-Week Low | $1.98 | $28.90 |
Typical Hold Time | 0 Days | 115 Days |
Enterprise Value | $10.97B | $12.49B |
Dividend Yield | — | 1.93% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
MTCH trades at $40.86, up 0.59% today, with a bullish technical signal and strong cash flow growth. The company reported a net income margin of 20.17% for 2025, with recent earnings beats in Q4 2025 and Q2 2026. Revenue remains stable at $3.49B, while analyst consensus is a Buy with a $42.29 price target. Positive sentiment is driven by margin expansion and Hinge's growth, though high debt levels and mixed quarterly results present some caution.
The outlook for MTCH is cautiously optimistic, with upside to the consensus target offering ~3.5% potential gain. Strengths include robust profitability, solid cash generation, and product innovation, but risks involve elevated debt, competitive pressures, and reliance on Tinder's turnaround. Investors should weigh strong fundamentals against execution risks in a dynamic dating app market.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About ImmunityBio Inc. Common Stock
ImmunityBio develops immune-based therapies for cancer and infectious diseases. Its programs are designed to activate and strengthen the body’s immune response.
Read more on IBRX →About Match Group Inc
Match Group is a provider of online dating products. The firm became public in 2015 and was more than 80% owned by IAC/InterActiveCorp until IAC spun it off in the second quarter of 2020. The company has a vast portfolio of different online dating service providers, including Tinder, Match.com, OkCupid, Plenty of Fish, and Meetic. Match Group has more than 45 brands of online dating sites and/or apps, from which it generates user fee revenue (95%) and advertising revenue (5%).
Read more on MTCH →
